Empowered Funds’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.74M Buy
646,861
+23,957
+4% +$267K 0.04% 570
2026
Q1
$7.41M Buy
622,904
+8,602
+1% +$88K 0.05% 493
2025
Q4
$6.12M Sell
614,302
-15,696
-2% -$150K 0.1% 216
2025
Q3
$5.64M Sell
629,998
-88,979
-12% -$824K 0.06% 442
2025
Q2
$6.78M Sell
718,977
-9,289
-1% -$82K 0.08% 343
2025
Q1
$7.89M Buy
728,266
+14,623
+2% +$147K 0.11% 222
2024
Q4
$6.79M Buy
713,643
+142,743
+25% +$1.44M 0.1% 283
2024
Q3
$6.41M Buy
570,900
+29,078
+5% +$309K 0.1% 284
2024
Q2
$5.42M Buy
541,822
+39,060
+8% +$397K 0.09% 280
2024
Q1
$5.79M Buy
502,762
+38,084
+8% +$323K 0.1% 270
2023
Q4
$3.39M Buy
464,678
+42,031
+10% +$331K 0.09% 340
2023
Q3
$3.85M Buy
422,647
+33,978
+9% +$407K 0.11% 239
2023
Q2
$4.73M Buy
+388,669
New +$4.33M 0.17% 145

Other funds holding AHCO

Empowered Funds's AHCO Position: Q2 2026 in Review

Empowered Funds increased its AdaptHealth (AHCO) stake by 3.8% in Q2 2026, buying an estimated $267K and bringing the position to 646,861 shares worth $6.74M. The position accounts for 0.04% of the portfolio, ranked #570.

Empowered Funds first reported a position in AHCO in Q2 2023 and has held it in 13 quarters since. The position peaked at $7.89M in Q1 2025. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Empowered Funds held 646,861 shares of AdaptHealth worth $6.74M as of Q2 2026.
  • Empowered Funds bought 23,957 AdaptHealth shares in Q2 2026, an estimated $267K.
  • AdaptHealth made up 0.04% of Empowered Funds's portfolio in Q2 2026, its #570 holding.
  • Empowered Funds first reported a position in AdaptHealth in Q2 2023 and has held it in 13 quarters since.
  • Empowered Funds's AdaptHealth position peaked at $7.89M in Q1 2025.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.